ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 117 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $490,000 | -68.5% | 22,600 | -59.1% | 0.00% | -75.0% |
| Q2 2022 | $1,554,000 | -50.7% | 55,300 | -19.0% | 0.00% | -50.0% |
| Q1 2022 | $3,151,000 | -43.9% | 68,300 | +2.2% | 0.01% | -42.9% |
| Q4 2021 | $5,615,000 | -38.1% | 66,800 | -50.9% | 0.01% | -41.7% |
| Q3 2021 | $9,070,000 | +212.9% | 136,100 | +149.7% | 0.02% | +200.0% |
| Q2 2021 | $2,899,000 | +80.6% | 54,500 | +47.3% | 0.01% | +100.0% |
| Q1 2021 | $1,605,000 | +136.0% | 37,000 | +182.4% | 0.00% | +100.0% |
| Q4 2020 | $680,000 | – | 13,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |